Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JUNE 20, 2019 FBO #6418
SOURCES SOUGHT

66 -- MALDI-TOF system

Notice Date
6/18/2019
 
Notice Type
Synopsis
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
3900 NCTR Road, HFT-320 Bldg 50 | Rm 421 Jefferson AR 72079
 
ZIP Code
72079
 
Solicitation Number
FDA-SSNT-1213837
 
Response Due
6/25/2019
 
Point of Contact
ROOSEVELT D. WALKER, CONTRACT SPECIALIST, Phone 8705437405
 
E-Mail Address
roosevelt.walker@fda.hhs.gov
 
Small Business Set-Aside
Total Small Business
 
Description
MARKET RESEARCH PURPOSES ONLY NOT A REQUEST FOR PROPOSAL OR SOLICITATION The U.S. Food and Drug Administration (FDA), is conducting market research to support the Center for Biologics Evaluation and Research (CBER), to require label free Protein Stability Detection instrument to be used for multiple projects in the CBER lab. The FDA is seeking small business sources to determine the availability and capability of small business manufacturers or small businesses capable of supplying, a U.S. made product of a small business manufacturer or producer for the items described herein. Other than small business concerns are also encouraged to submit capability statements. The following information is provided to assist the FDA in conducting Market Research to identify potential contractors for this effort. The associated North American Industry Classification System (NAICS) Code is 334516- Analytical Laboratory Instrument Manufacturing; 1,000 employee Small Business Size standard. The FDA/CBER requires for a MALDI-TOF system for efficient identification and quantification of bacterial species in a complex sample. label free Protein Stability Detection instrument. The system will be used to assess the microbial composition of mice following various treatments and infections. It will also be used for the development/assessment of assays to be used for quantification of bacterial strains in complex Live Biotherapeutic Products containing multiple different, but related, bacterial species. NOTE: THIS NOTICE WAS NOT POSTED TO FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (18-JUN-2019); HOWEVER, IT DID APPEAR IN THE FEDBIZOPPS FTP FEED ON THIS DATE. PLEASE CONTACT 877-472-3779 or fbo.support@gsa.gov REGARDING THIS ISSUE.
 
Web Link
Link To Document
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA-SSNT-1213837/listing.html)
 
Place of Performance
Address: US Food and Drug Administration Center for Biologics Evaluation and Research (CBER) 10903 New Hampshire Avenue Building 52/72, Room 3376 Silver Spring, MD
Zip Code: 20993
Country: US
 
Record
SN05343583-F 20190620/190618230024 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.